Bank of Montreal’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-502,099
Closed -$5.05M 4322
2022
Q4
$5.05M Hold
502,099
﹤0.01% 1287
2022
Q3
$4.94K Sell
502,099
-131,000
-21% -$1.29M ﹤0.01% 1360
2022
Q2
$6.21K Buy
633,099
+131,000
+26% +$1.28M ﹤0.01% 1299
2022
Q1
$4.89M Hold
502,099
﹤0.01% 1508
2021
Q4
$4.89M Buy
502,099
+2,099
+0.4% +$20.4K ﹤0.01% 1231
2021
Q3
$4.88M Buy
+500,000
New +$4.85M ﹤0.01% 1647

Other funds holding AONC

Bank of Montreal's AONC Position: Q1 2023 in Review

Bank of Montreal sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 502,099 shares — an estimated $5.05M sold.

Bank of Montreal first reported a position in AONC in Q3 2021 and held it in 6 quarters. The position peaked at $5.05M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Bank of Montreal reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 502,099 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $5.05M.
  • Bank of Montreal first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
  • Bank of Montreal's American Oncology Network, Inc. Class A Common Stock position peaked at $5.05M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.